Bulletin
Investor Alert

Regulus Therapeutics Inc.

NAS: RGLS

GO
/marketstate/country/us

Market closed

/zigman2/quotes/202916513/composite

$

1.40

Change

0.00 0.00%

Volume

Volume 12,817

Dec 4, 2023, 3:30 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202916513/composite

Previous close

$ 1.40

$ 1.40

Change

0.00 0.00%

Day low

Day high

$1.28

$1.40

Open
Open: 1.28

52 week low

52 week high

$0.76

$2.14

Open

Market cap

$28.31M

Average volume

19,110

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.59

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgls

MarketWatch News on RGLS

  1. How Biotech Is Targeting RNA to Cure Diseases

    7:01 a.m. Sept. 3, 2019

    - Barron's Online

  2. Regulus Therapeutics downgraded to market perform from outperform at Leerink

    9:01 a.m. July 10, 2018

    - Tomi Kilgore

  3. Regulus Therapeutics stock price target cut to 35 cents from $2.00 at Leerink

    9:01 a.m. July 10, 2018

    - Tomi Kilgore

  4. Regulus Therapeutics stock price target cut to $6 from $8 at Wedbush Securities

    9:13 a.m. March 6, 2017

    - Tomi Kilgore

  5. Baby Boomers Pitch In

    3:24 a.m. Dec. 3, 2016

    - Barron's Online

  6. Regulus Therapeutics stock price target cut to $15 from $35 at Wedbush Securities

    6:22 a.m. June 28, 2016

    - Tomi Kilgore

  7. Regulus Therapeutics' stock resumes trade; plunges 56% in after-hours trade

    3:41 p.m. June 27, 2016

    - Tomi Kilgore

  8. Regulus Therapeutics' stock halted; FDA places hepatitis treatment on clinical hold

    3:22 p.m. June 27, 2016

    - Tomi Kilgore

  9. Regulus Therapeutics' stock soars 39% premarket after upbeat results from Hep-C treatment study

    7:44 a.m. Feb. 17, 2016

    - Tomi Kilgore

  10. Russell 2000 approaches the 200-day average

    11:35 a.m. Nov. 30, 2015

    - Michael Ashbaugh

  11. Hopes for single-dose Hepatitis C drug fade

    3:30 p.m. Feb. 9, 2015

    - Russ Britt

  12. 6 stocks to watch

    3:28 p.m. Dec. 10, 2014

    - The Trading Deck

  13. 6 stocks to watch

    3:05 p.m. Nov. 5, 2014

    - The Trading Deck

  14. Loading more headlines...

Analyst Ratings

Rates »

Link to MarketWatch's Slice.